skip to Main Content
Get Board Certified
BECOME CERTIFIED
Overview
Board Eligibility
Fees
FAQs
Candidate Handbook
ABOUT THE EXAM
BCMTMS™ Exam Overview
Examination Scheduling
Testing Dates
Exam Content Outline
Exam Prep Resources
Handbook
test
APPLY NOW
Maintain Certification
MAINTAIN CERTIFICATION
Renewal Cycle
Recertification Process
Recertification Handbook
MTM Certificate
Menu 3
About
ABOUT NBMTM
Mission, Vision & Values
History
Leadership & Governance
Accreditation
Volunteer Opportunities
ABOUT OUR CERTIFICATION
MTM Certification
BCMTMS
A Trusted Credential
Reports and Pass Rates
my
NBMTM
Search
Search
Submit
Menu
Feed Items
Home
|
Pediatric tonsil cancer: A national and institutional perspective
Pediatric tonsil cancer: A national and institutional perspective
March 26, 2018
Pediatric tonsil cancer: A national and institutional perspective
Published on 03/25/2018
Tweet
Share
Share
previous post:
Nilotinib in locally advanced pigmented villonodular synovitis: A multicentre, open-label, single-arm, phase 2 trial
next post:
Aberrant high expression level of MORC2 is a common character in multiple cancers
Get Board Certified
Overview
Board Eligibility
BCMTMS™ Exam Overview
Testing Dates
Fees
Exam Content Outline
Exam Prep Resources
Candidate Handbook
Maintain Certification
Renew Certification
Renewal Cycle
Recertification Process
Recertification Handbook
About
Mission, Vision & Values
History
Leadership & Governance
Accreditation
MTM Certification
A Trusted Credential
Login
Back To Top
